1
|
Notaro NM, Dyck DJ. Regulation of peripheral tissue substrate metabolism by the gut-derived hormone ghrelin. Metabol Open 2024; 21:100279. [PMID: 38487670 PMCID: PMC10937159 DOI: 10.1016/j.metop.2024.100279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2024] [Revised: 02/21/2024] [Accepted: 02/22/2024] [Indexed: 03/17/2024] Open
Abstract
Ghrelin increases in the circulation prior to entrained mealtimes, with the acylated (AG) form functioning to stimulate food intake and growth hormone release. Acutely, AG induces whole-body insulin resistance, potentially to maintain glycemia between meals. Alternatively, chronic administration of both AG and the unacylated isoform of ghrelin (unAG) is associated with improved skeletal muscle insulin sensitivity as well as reduced intramuscular lipids and inflammation. This may be due to effects on lipid metabolism, with ghrelin promoting storage of fat in adipose and liver while stimulating oxidation in skeletal muscle, preventing ectopic lipid accumulation. This is of specific relevance in the handling of meal-derived lipids, as ghrelin rises preprandially with effects persisting for 2-3 h following exposure in skeletal muscle, coinciding with elevated plasma FFAs. We hypothesize that ghrelin acts as a preparatory signal for incoming lipids, as well as a regulatory hormone for their use and storage. The effects of ghrelin on skeletal muscle are lost with high fat diet feeding and physical inactivity, potentially being implicated in the pathogenesis of metabolic disease. This review summarizes the metabolic effects of both ghrelin isoforms on peripheral tissues including the pancreas, adipose, liver, and skeletal muscle. Additionally, we speculate on the physiological relevance of these effects in vivo and suggest that ghrelin may be a key regulatory hormone for nutrient handling in the postprandial state.
Collapse
Affiliation(s)
- Nicole M. Notaro
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON, Canada
| | - David J. Dyck
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON, Canada
| |
Collapse
|
2
|
Kutsche HS, Schreckenberg R, Schlüter KD. Uncoupling Proteins in Striated Muscle Tissue: Known Facts and Open Questions. Antioxid Redox Signal 2022; 37:324-335. [PMID: 35044239 DOI: 10.1089/ars.2021.0258] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Significance: Uncoupling proteins (UCPs) are a family of proteins that allow proton leakage across the inner mitochondrial membrane. Although UCP1, also known as thermogenin, is well known and important for heat generation in brown adipose tissue, striated muscles express two distinct members of UCP, namely UCP2 and UCP3. Unlike UCP1, the main function of UCP2 and UCP3 does not appear to be heat production. Recent Advances: Interestingly, UCP2 is the main isoform expressed in cardiac tissues, whereas UCP3 is the dominant isoform in skeletal muscles. In the past years, researchers have started to investigate the regulation of UCP2 and UCP3 expression in striated muscles. Furthermore, concepts about the proposed functions of UCP2 and UCP3 in striated muscles are developed but are still a matter of debate. Critical Issues: Potential functions of UCP2 and UCP3 in striated muscles include a role in protection against mitochondria-dependent oxidative stress, as transporter for pyruvate, fatty acids, and protons into and out of the mitochondria, and in metabolic sensing. In this context, the different isoform expression of UCP2 and UCP3 in the skeletal and cardiac muscle may be related to different metabolic requirements of the two organs. Future Directions: The level of expression of UCP2 and UCP3 in striated muscles changes in different disease stages. This suggests that UCPs may become drug targets for therapy in the future. Antioxid. Redox Signal. 37, 324-335.
Collapse
Affiliation(s)
| | - Rolf Schreckenberg
- Institute of Physiology, Justus-Liebig University Giessen, Giessen, Germany
| | | |
Collapse
|
3
|
Lovell AJ, Hoecht EM, Hucik B, Cervone DT, Dyck DJ. The effects of diet and chronic exercise on skeletal muscle ghrelin response. Metabol Open 2022; 14:100182. [PMID: 35340718 PMCID: PMC8942827 DOI: 10.1016/j.metop.2022.100182] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 03/14/2022] [Accepted: 03/16/2022] [Indexed: 11/20/2022] Open
Abstract
Background Recent findings indicate that ghrelin, particularly the unacylated form (UnAG), acutely stimulates skeletal muscle fatty acid oxidation (FAO) and can preserve insulin signaling and insulin-stimulated glucose uptake in the presence of high concentrations of saturated fatty acids. However, we recently reported that the stimulatory effect of ghrelin on FAO and subsequent ability to protect insulin stimulated glucose uptake was lost following 6-weeks (6w) of chronic high fat feeding. In the current study we examined the effects of both short-term 5 day (5d) and chronic 6w high-fat diet (HFD) on muscle ghrelin response, and whether exercise training could prevent the development of muscle ghrelin resistance with 6w of HFD Methods and Results Soleus muscle strips were isolated from male rats to determine the direct effects of acylated (AG) and UnAG isoforms on FAO and glucose uptake. A 5d HFD did not alter the response of soleus muscle to AG or UnAG. Conversely, 6w of HFD was associated with a loss of ghrelin's ability to stimulate FAO and protect insulin stimulated glucose uptake. Muscle response to UnAG remained intact following the 6w HFD with chronic exercise training. Unexpectedly, muscle response to both AG and UnAG was also lost after 6w of low-fat diet (LFD) consumption. Protein content of the classic ghrelin receptor, GHS-R1a, was not affected by diet or training. Corticotropin-releasing hormone receptor-2 (CRF-2R) content, a putative receptor for ghrelin in muscle, was significantly decreased in soleus from 6w HFD-fed animals and increased following exercise training. This may explain the protection of UnAG response with training in HFD-fed rats but does not explain why ghrelin response was also lost in LFD-fed animals. Conclusions UnAG protects muscle glucose uptake during acute lipid oversupply, likely due to its ability to stimulate FAO. This effect is lost in 6w HFD-fed animals but protected with exercise training. Unexpectedly, ghrelin response was lost in 6w LFD-fed animals. The loss of ghrelin response in muscle with a LFD cannot be explained by a change in putative ghrelin receptor content. We believe that the sedentary nature of the animals is a major factor in the development of muscle ghrelin resistance and warrants further research. Ghrelin stimulates fatty acid oxidation in skeletal muscle. This stimulation is strongly associated with protection from acute fat overload. Prolonged sedentary behaviour and a high fat diet impair ghrelin's ability to stimulate fatty acid oxidation. Exercise training preserves ghrelin's positive effects on skeletal muscle.
Collapse
|
4
|
Hucik B, Lovell AJ, Hoecht EM, Cervone DT, Mutch DM, Dyck DJ. Regulation of adipose tissue lipolysis by ghrelin is impaired with high-fat diet feeding and is not restored with exercise. Adipocyte 2021; 10:338-349. [PMID: 34224298 PMCID: PMC8259717 DOI: 10.1080/21623945.2021.1945787] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Abstract
Ghrelin is released from the stomach as an anticipatory signal prior to a meal and decreases immediately after. Previous research has shown that both acylated (AG) and unacylated (UnAG) ghrelin blunt adrenoreceptor-stimulated lipolysis in rat white adipose tissue (WAT) ex vivo. We investigated whether acute or chronic consumption of a high fat diet (HFD) impaired the ability of ghrelin to regulate adipose tissue lipolysis, and if this impairment could be restored with exercise. After 5 days (5d) of a HFD, or 6 weeks (6 w) of a HFD (60% kcal from fat) with or without exercise training, inguinal and retroperitoneal WAT was collected from anesthetized rats for adipose tissue organ culture. Samples were treated with 1 μM CL 316,243 (CL; lipolytic control), 1 μM CL+150 ng/ml AG or 1 μM CL+150 ng/ml UnAG. Incubation media and tissue were collected after 2 hours. Colorometric assays were used to determine glycerol and free fatty acid (FFA) concentrations in media. Western blots were used to quantify the protein content of lipolytic enzymes and ghrelin receptors in both depots. CL stimulated lipolysis was evidenced by increases in glycerol (p < 0.0001) and FFA (p < 0.0001) concentrations in media compared to control. AG decreased CL-stimulated glycerol release in inguinal WAT from 5d LFD rats (p = 0.0097). Neither AG nor UnAG blunted lipolysis in adipose tissue from 5d or 6 w HFD-fed rats, and exercise did not restore ghrelin’s anti-lipolytic ability in 6 w HFD-fed rats. Overall, this study demonstrates that HFD consumption impairs ghrelin’s ability to regulate adipose tissue lipolysis.
Collapse
Affiliation(s)
- Barbora Hucik
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
| | - Andrew J. Lovell
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
| | - Evan M. Hoecht
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
| | - Daniel T. Cervone
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
| | - David M. Mutch
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
| | - David J. Dyck
- Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada
| |
Collapse
|
5
|
Elbaz M, Gershon E. Ghrelin, via corticotropin-releasing factor receptors, reduces glucose uptake and increases lipid content in mouse myoblasts cells. Physiol Rep 2021; 9:e14654. [PMID: 33463908 PMCID: PMC7814488 DOI: 10.14814/phy2.14654] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 10/27/2020] [Accepted: 10/27/2020] [Indexed: 12/20/2022] Open
Abstract
Ghrelin and the corticotropin-releasing factor (CRF) family are known regulators of cellular metabolism and energy balance. We previously demonstrated that myoblast glucose metabolism is regulated by ghrelin and that this effect is mediated by CRF receptor type 2 (CRF-R2). Here we explored the effect of des-acyl ghrelin, the major circulating isoform of ghrelin, on cellular metabolism in mouse myoblast C2C12 cells, and examined whether CRF family receptors mediate its metabolic effects in muscle cells. C2C12 cells were exposed to des-acyl ghrelin with or without the CRF-R1- and CRF-R2-specific antagonists antalarmin or antisauvagine-30, respectively. Des-acyl ghrelin reduced glucose uptake and expression of the glucose transporter GLUT4, but induced retinol-binding protein 4 (RBP4) expression. Antalarmin and antisauvagine-30 inhibited the induction of glucose uptake by des-acyl ghrelin and its effect on GLUT4 and RBP4 expression. Moreover, treating C2C12 cells with des-acyl ghrelin resulted in cAMP activation in response to the CRF-R1-specific ligand stressin, and the CRF-R2-specific ligand Ucn3. Furthermore, des-acyl ghrelin reduced the expression of uncoupling proteins UCP2 and UCP3. Adding antalarmin or antisauvagine-30 to the medium reversed this effect. Finally, des-acyl ghrelin elevated lipid content and acetyl-CoA carboxylase expression in C2C12 cells. Our results suggest that during food deprivation, des-acyl ghrelin signals the muscle cells that glucose levels are low and that they should switch to fatty acids for their metabolic fuel.
Collapse
Affiliation(s)
- Michal Elbaz
- Department of Ruminant ScienceAgricultural Research OrganizationRishon LeZionIsrael
| | - Eran Gershon
- Department of Ruminant ScienceAgricultural Research OrganizationRishon LeZionIsrael
| |
Collapse
|
6
|
Cervone DT, Lovell AJ, Dyck DJ. Regulation of adipose tissue and skeletal muscle substrate metabolism by the stomach-derived hormone, ghrelin. Curr Opin Pharmacol 2020; 52:25-32. [DOI: 10.1016/j.coph.2020.04.005] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2020] [Revised: 04/08/2020] [Accepted: 04/08/2020] [Indexed: 12/17/2022]
|
7
|
Wu CS, Wei Q, Wang H, Kim DM, Balderas M, Wu G, Lawler J, Safe S, Guo S, Devaraj S, Chen Z, Sun Y. Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice. J Gerontol A Biol Sci Med Sci 2020; 75:621-630. [PMID: 30407483 PMCID: PMC7328200 DOI: 10.1093/gerona/gly256] [Citation(s) in RCA: 35] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Indexed: 12/12/2022] Open
Abstract
Sarcopenia is the aging-associated progressive loss of skeletal muscle; however, the pathogenic mechanism of sarcopenia is not clear. The orexigenic hormone ghrelin stimulates growth hormone secretion, increases food intake, and promotes adiposity. Here we showed that fasting-induced muscle loss was exacerbated in old ghrelin-null (Ghrl-/-) mice, exhibiting decreased expression of myogenic regulator MyoD and increased expression of protein degradation marker MuRF1, as well as altered mitochondrial function. Moreover, acylated ghrelin and unacylated ghrelin treatments significantly increased mitochondrial respiration capacity in muscle C2C12 cells. Consistently, acylated ghrelin and unacylated ghrelin treatments effectively increased myogenic genes and decreased degradation genes in the muscle in fasted old Ghrl-/- mice, possibly by stimulating insulin and adenosine monophosphate-activated protein kinase pathways. Furthermore, Ghrl-/- mice showed a profile of pro-inflammatory gut microbiota, exhibiting reduced butyrate-producing bacteria Roseburia and ClostridiumXIVb. Collectively, our results showed that ghrelin has a major role in the maintenance of aging muscle via both muscle-intrinsic and -extrinsic mechanisms. Acylated ghrelin and unacylated ghrelin enhanced muscle anabolism and exerted protective effects for muscle atrophy. Because unacylated ghrelin is devoid of the obesogenic side effect seen with acylated ghrelin, it represents an attractive therapeutic option for sarcopenia.
Collapse
Affiliation(s)
- Chia-Shan Wu
- Department of Nutrition and Food Science, Texas A&M University, College Station
- USDA/ARS Children’s Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
| | - Qiong Wei
- USDA/ARS Children’s Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
- Division of Endocrinology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province
| | - Hongying Wang
- Department of Nutrition and Food Science, Texas A&M University, College Station
- Laboratory of Lipid and Glucose Metabolism, The First Affiliated Hospital of Chongqing Medical University, China
| | - Da Mi Kim
- Department of Nutrition and Food Science, Texas A&M University, College Station
| | - Miriam Balderas
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
| | - Guoyao Wu
- Department of Animal Science, Texas A&M University, College Station
| | - John Lawler
- Department of Health and Kinesiology, Texas A&M University, College Station
| | - Stephen Safe
- Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station
| | - Shaodong Guo
- Department of Nutrition and Food Science, Texas A&M University, College Station
| | - Sridevi Devaraj
- Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas
| | - Zheng Chen
- The University of Texas Health Science Center at Houston
| | - Yuxiang Sun
- Department of Nutrition and Food Science, Texas A&M University, College Station
- USDA/ARS Children’s Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
| |
Collapse
|
8
|
Unacylated ghrelin stimulates fatty acid oxidation to protect skeletal muscle against palmitate-induced impairment of insulin action in lean but not high-fat fed rats. Metabol Open 2020; 5:100026. [PMID: 32812929 PMCID: PMC7424793 DOI: 10.1016/j.metop.2020.100026] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2019] [Revised: 01/28/2020] [Accepted: 01/29/2020] [Indexed: 11/29/2022] Open
Abstract
Background Ghrelin is a gut hormone that spikes in circulation before mealtime. Recent findings suggest that both ghrelin isoforms stimulate skeletal muscle fatty acid oxidation, lending to the possibility that it may regulate skeletal muscle’s handling of meal-derived substrates. It was hypothesized in the current study that ghrelin may preserve muscle insulin response during conditions of elevated saturated fatty acid (palmitate) availability by promoting its oxidation. Methods and results Soleus muscle strips were isolated from male rats to determine the direct effects of ghrelin isoforms on fatty acid oxidation, glucose uptake and insulin signaling. We demonstrate that unacylated ghrelin (UnAG) is the more potent stimulator of skeletal muscle fatty acid oxidation. Both isoforms of ghrelin generally protected muscle from impaired insulin-mediated phosphorylation of AKT Ser473 and Thr308, as well as downstream phosphorylation of AS160 Ser588 during high palmitate exposure. However, only UnAG was able to preserve insulin-stimulated glucose uptake during exposure to high palmitate concentrations. The use of etomoxir, an irreversible inhibitor of carnitine palmitoyltransferase (CPT-1) abolished this protection, strongly suggesting that UnAG’s stimulation of fatty acid oxidation may be essential to this protection. To our knowledge, we are also the first to investigate the impact of a chronic high-fat diet on ghrelin’s actions in muscle. Following 6 wks of a high-fat diet, UnAG was unable to preserve insulin-stimulated signaling or glucose transport during an acute high palmitate exposure. UnAG was also unable to further stimulate 5′ AMP-activated protein kinase (AMPK) or fatty acid oxidation during high palmitate exposure. Corticotropin-releasing hormone receptor-2 (CRF-2R) content was significantly decreased in muscle from high-fat fed animals, which may partially account for the loss of UnAG’s effects. Conclusions UnAG is able to protect muscle from acute lipid exposure, likely due to its ability to stimulation fatty acid oxidation. This effect is lost in high-fat fed animals, implying a resistance to ghrelin at the level of the muscle. The underlying mechanisms accounting for ghrelin resistance in high fat-fed animals remain to be discovered. Saturated lipids acutely impair muscle insulin signaling and glucose transport. Ghrelin isoforms consistently protect insulin signaling from lipid detriment. Unacylated ghrelin more potently stimulates fat oxidation, preserving glucose transport. Muscle of chronic high fat-fed rats may be resistant to ghrelin’s metabolic effects.
Collapse
|
9
|
Gortan Cappellari G, Barazzoni R. Ghrelin forms in the modulation of energy balance and metabolism. Eat Weight Disord 2019; 24:997-1013. [PMID: 30353455 DOI: 10.1007/s40519-018-0599-6] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2018] [Accepted: 10/16/2018] [Indexed: 02/06/2023] Open
Abstract
Ghrelin is a gastric hormone circulating in acylated (AG) and unacylated (UnAG) forms. This narrative review aims at presenting current emerging knowledge on the impact of ghrelin forms on energy balance and metabolism. AG represents ~ 10% of total plasma ghrelin, has an appetite-stimulating effect and is the only form for which a receptor has been identified. Moreover, other metabolic AG-induced effects have been reported, including the modulation of glucose homeostasis with stimulation of liver gluconeogenesis, the increase of fat mass and the improvement of skeletal muscle mitochondrial function. On the other hand, UnAG has no orexigenic effects, however recent reports have shown that it is directly involved in the modulation of skeletal muscle energy metabolism by improving a cluster of interlinked functions including mitochondrial redox activities, tissue inflammation and insulin signalling and action. These findings are in agreement with human studies which show that UnAG circulating levels are positively associated with insulin sensitivity both in metabolic syndrome patients and in a large cohort from the general population. Moreover, ghrelin acylation is regulated by a nutrient sensor mechanism, specifically set on fatty acids availability. These recent findings consistently point towards a novel independent role of UnAG as a regulator of muscle metabolic pathways maintaining energy status and tissue anabolism. While a specific receptor for UnAG still needs to be identified, recent evidence strongly supports the hypothesis that the modulation of ghrelin-related molecular pathways, including those involved in its acylation, may be a potential novel target in the treatment of metabolic derangements in disease states characterized by metabolic and nutritional complications.Level of evidence Level V, narrative review.
Collapse
Affiliation(s)
- Gianluca Gortan Cappellari
- Department of Medical, Surgical and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
| | - Rocco Barazzoni
- Department of Medical, Surgical and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
- Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), Trieste, Italy.
| |
Collapse
|
10
|
Kraft EN, Cervone DT, Dyck DJ. Ghrelin stimulates fatty acid oxidation and inhibits lipolysis in isolated muscle from male rats. Physiol Rep 2019; 7:e14028. [PMID: 30963694 PMCID: PMC6453820 DOI: 10.14814/phy2.14028] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 02/27/2019] [Accepted: 02/27/2019] [Indexed: 11/24/2022] Open
Abstract
Ghrelin is classically known as a central appetite-stimulating hormone but has recently been recognized to have a significant role in peripheral tissue energy metabolism. However, the direct effects of ghrelin on skeletal muscle, a major site for glucose and lipid disposal, remain understudied. We found that the two major ghrelin isoforms, acylated and unacylated ghrelin, were able to significantly increase skeletal muscle fatty acid oxidation (~20%) while incorporation of fatty acids into major lipid pools remained unchanged. The increase in fatty acid oxidation was accompanied by increases in acetyl-CoA carboxylase phosphorylation, a downstream target of AMPK. Ghrelin isoforms had no independent effect on lipolysis under unstimulated conditions, but nearly completely abolished epinephrine-stimulated lipolysis. This effect was generally, but not consistently related to a blunting in the phosphorylation of HSL activation sites, Ser660 and 563. Taken together, these findings suggest that ghrelin isoforms have a direct, acute effect on fatty acid oxidation and lipolysis.
Collapse
Affiliation(s)
- Emily N. Kraft
- Department of Human Health and Nutritional SciencesUniversity of GuelphGuelphOntarioCanada
| | - Daniel T. Cervone
- Department of Human Health and Nutritional SciencesUniversity of GuelphGuelphOntarioCanada
| | - David J. Dyck
- Department of Human Health and Nutritional SciencesUniversity of GuelphGuelphOntarioCanada
| |
Collapse
|
11
|
Cervone DT, Dyck DJ. Acylated and unacylated ghrelin do not directly stimulate glucose transport in isolated rodent skeletal muscle. Physiol Rep 2018; 5:5/13/e13320. [PMID: 28676552 PMCID: PMC5506520 DOI: 10.14814/phy2.13320] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2017] [Revised: 05/15/2017] [Accepted: 05/19/2017] [Indexed: 12/22/2022] Open
Abstract
Emerging evidence implicates ghrelin, a gut-derived, orexigenic hormone, as a potential mediator of insulin-responsive peripheral tissue metabolism. However, in vitro and in vivo studies assessing ghrelin's direct influence on metabolism have been controversial, particularly due to confounding factors such as the secondary rise in growth hormone (GH) after ghrelin injection. Skeletal muscle is important in the insulin-stimulated clearance of glucose, and ghrelin's exponential rise prior to a meal could potentially facilitate this. This study was aimed at elucidating any direct stimulatory action that ghrelin may have on glucose transport and insulin signaling in isolated rat skeletal muscle, in the absence of confounding secondary factors. Oxidative soleus and glycolytic extensor digitorum longus skeletal muscles were isolated from male Sprague Dawley rats in the fed state and incubated with various concentrations of acylated and unacylated ghrelin in the presence or absence of insulin. Ghrelin did not stimulate glucose transport in either muscle type, with or without insulin. Moreover, GH had no acute, direct stimulatory effect on either basal or insulin-stimulated muscle glucose transport. In agreement with the lack of observed effect on glucose transport, ghrelin and GH also had no stimulatory effect on Ser473 AKT or Thr172 AMPK phosphorylation, two key signaling proteins involved in glucose transport. Furthermore, to our knowledge, we are among the first to show that ghrelin can act independent of its receptor and cause an increase in calmodulin-dependent protein kinase 2 (CaMKII) phosphorylation in glycolytic muscle, although this was not associated with an increase in glucose transport. We conclude that both acylated and unacylated ghrelin have no direct, acute influence on skeletal muscle glucose transport. Furthermore, the immediate rise in GH in response to ghrelin also does not appear to directly stimulate glucose transport in muscle.
Collapse
Affiliation(s)
- Daniel T Cervone
- Department of Human Health and Nutritional Sciences, University of Guelph, Ontario, Canada
| | - David J Dyck
- Department of Human Health and Nutritional Sciences, University of Guelph, Ontario, Canada
| |
Collapse
|
12
|
Stievenard A, Méquinion M, Andrews ZB, Destée A, Chartier-Harlin MC, Viltart O, Vanbesien-Mailliot CC. Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways. Neurosci Biobehav Rev 2017; 73:255-275. [DOI: 10.1016/j.neubiorev.2016.11.021] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Revised: 11/23/2016] [Accepted: 11/25/2016] [Indexed: 12/21/2022]
|
13
|
Honig H, Ofer L, Elbaz M, Kaim M, Shinder D, Gershon E. Seasonal and parity effects on ghrelin levels throughout the estrous cycle in dairy cows. Gen Comp Endocrinol 2016; 235:64-69. [PMID: 27288640 DOI: 10.1016/j.ygcen.2016.06.006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/28/2015] [Revised: 05/23/2016] [Accepted: 06/07/2016] [Indexed: 12/23/2022]
Abstract
In dairy cows, heat stress depresses appetite, leading to decreased food intake, a negative energy balance, and modifies ghrelin levels. Ghrelin is a gut-brain peptide with two major forms: acylated, with an O-n-octanoylated serine in position 3, and nonacylated. To date, the effect of heat stress and estrous cycle on ghrelin secretion in dairy cows has not been studied. We characterized ghrelin secretion during the estrous cycle in each, the winter and the summer seasons. We further examined the effects of parity on ghrelin secretion. Blood was collected from 10 primiparous or multiparous Israeli-Holstein dairy cows throughout the estrous cycle, in both, the hot and cold seasons. The levels of acylated and total ghrelin were measured in the blood samples. We found that both acylated and total ghrelin levels during heat stress were lower than their respective levels in the winter in both, primiparous and multiparous cows. No differences in acylated and total ghrelin levels were found between primiparous and multiparous cows in both seasons. We further found that in multiparous but not primiparous cows acylated ghrelin secretion oscillated during the estrous cycle in both seasons. Its levels peaked on the last days of the first follicular wave and on the days before and during ovulation. Interestingly, we found that elevated acylated ghrelin levels correlated with conception success and increased total ghrelin levels were associated with successful conception from first insemination. Our data is the first to demonstrate seasonal variation in ghrelin secretion. This study provides evidence for the yet unfamiliar link between heat stress, ghrelin and fertility. Increased circulating acylated ghrelin may contribute to improved fertility in dairy cows. It further raises the possibility of a link between ghrelin levels and successful inseminations. Further research is required to determine the effects of ghrelin on dairy cow performance.
Collapse
Affiliation(s)
- Hen Honig
- Institute of Animal Sciences, Agricultural Research Organization, PO Box 6, Bet-Dagan 50250, Israel
| | - Lior Ofer
- Department of Ruminant Science, Agricultural Research Organization, PO Box 6, Bet Dagan 50250, Israel
| | - Michal Elbaz
- Department of Ruminant Science, Agricultural Research Organization, PO Box 6, Bet Dagan 50250, Israel
| | - Moshe Kaim
- Department of Ruminant Science, Agricultural Research Organization, PO Box 6, Bet Dagan 50250, Israel
| | - Dima Shinder
- Poultry and Aquaculture Sci. Department, Agricultural Research Organization, PO Box 6, Bet Dagan 50250, Israel
| | - Eran Gershon
- Department of Ruminant Science, Agricultural Research Organization, PO Box 6, Bet Dagan 50250, Israel.
| |
Collapse
|
14
|
Gong H, Liu L, Ni CX, Zhang Y, Su WJ, Lian YJ, Peng W, Zhang JP, Jiang CL. Dexamethasone rapidly inhibits glucose uptake via non-genomic mechanisms in contracting myotubes. Arch Biochem Biophys 2016; 603:102-9. [PMID: 27246478 DOI: 10.1016/j.abb.2016.05.020] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2016] [Revised: 05/25/2016] [Accepted: 05/26/2016] [Indexed: 12/31/2022]
Abstract
Glucocorticoids (GCs) are a class of steroid hormones that regulate multiple aspects of glucose homeostasis. In skeletal muscle, it is well established that prolonged GC excess inhibits glucose uptake and utilization through glucocorticoid receptor (GR)-mediated transcriptional changes. However, it remains obscure that whether the rapid non-genomic effects of GC on glucose uptake are involved in acute exercise stress. Therefore, we used electric pulse stimulation (EPS)-evoked contracting myotubes to determine whether the non-genomic actions of GC were involved and its underlying mechanism(s). Pretreatment with dexamethasone (Dex, 10 μM) significantly prevented contraction-stimulated glucose uptake and glucose transporter 4 (Glut4) translocation within 20 min in C2C12 myotubes. Neither GC nuclear receptor antagonist (RU486) nor protein synthesis inhibitor (cycloheximide, Chx) affected the rapid inhibition effects of Dex. AMPK and CaMKII-dependent signaling pathways were associated with the non-genomic effects of Dex. These results provide evidence that GC rapidly suppresses glucose uptake in contracting myotubes via GR-independent non-genomic mechanisms. AMPK and CaMKII-mediated Glut4 translocation may play a critical role in GC-induced rapid inhibition of glucose uptake.
Collapse
Affiliation(s)
- Hong Gong
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Lei Liu
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Chen-Xu Ni
- Department of Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, People's Republics of China
| | - Yi Zhang
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Wen-Jun Su
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Yong-Jie Lian
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Wei Peng
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Jun-Ping Zhang
- Department of Pharmacy, Second Military Medical University, Shanghai 200433, People's Republic of China
| | - Chun-Lei Jiang
- Laboratory of Stress Medicine, Faculty of Psychology and Mental Health, Second Military Medical University, Shanghai 200433, People's Republic of China.
| |
Collapse
|
15
|
Tamaki M, Hagiwara A, Miyashita K, Wakino S, Inoue H, Fujii K, Fujii C, Sato M, Mitsuishi M, Muraki A, Hayashi K, Doi T, Itoh H. Improvement of Physical Decline Through Combined Effects of Muscle Enhancement and Mitochondrial Activation by a Gastric Hormone Ghrelin in Male 5/6Nx CKD Model Mice. Endocrinology 2015; 156:3638-48. [PMID: 26241123 DOI: 10.1210/en.2015-1353] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Because a physical decline correlates with an increased risk of a wide range of disease and morbidity, an improvement of physical performance is expected to bring significant clinical benefits. The primary cause of physical decline in 5/6 nephrectomized (5/6Nx) chronic kidney disease model mice has been regarded as a decrease in muscle mass; however, our recent study showed that a decrease in muscle mitochondria plays a critical role. In the present study, we examined the effects of a gastric hormone ghrelin, which has been reported to promote muscle mitochondrial oxidation, on the physical decline in the chronic kidney disease model mice, focusing on the epigenetic modulations of a mitochondrial activator gene, peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). Ghrelin treatment improved a decline in exercise endurance of 5/6Nx mice, associated with an increase in both of the muscle mass and mitochondrial amount. The expression level of PGC-1α was decreased in the skeletal muscle of 5/6Nx mice, which was associated with an increase in the methylation ratio of the cytosine residue at 260 base pairs upstream of the initiation point. Conversely, ghrelin treatment de-methylated the cytosine residue and increased the expression of PGC-1α. A representative muscle anabolic factor, IGF-1, did not affect the expression of PGC-1α and muscle mitochondrial amount, although it increased muscle mass. As a result, IGF-1 treatment in 5/6Nx mice did not increase the decreased exercise endurance as effectively as ghrelin treatment did. These findings indicate an advantage of ghrelin treatment for a recovery of physical decline.
Collapse
MESH Headings
- AMP-Activated Protein Kinases/metabolism
- Animals
- Blotting, Western
- Cell Line
- DNA Methylation/drug effects
- Disease Models, Animal
- Electron Transport Complex IV/genetics
- Electron Transport Complex IV/metabolism
- Gene Expression/drug effects
- Ghrelin/blood
- Ghrelin/genetics
- Ghrelin/pharmacology
- Male
- Mice, Inbred C57BL
- Mitochondria, Muscle/drug effects
- Mitochondria, Muscle/genetics
- Mitochondria, Muscle/metabolism
- Motor Activity/drug effects
- Muscle Weakness/drug therapy
- Muscle Weakness/genetics
- Muscle Weakness/metabolism
- Muscle, Skeletal/drug effects
- Muscle, Skeletal/metabolism
- Muscle, Skeletal/pathology
- Myoblasts/drug effects
- Myoblasts/metabolism
- Nephrectomy
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha
- RNA Interference
- Receptors, Ghrelin/genetics
- Receptors, Ghrelin/metabolism
- Renal Insufficiency, Chronic/complications
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription Factors/genetics
- Transcription Factors/metabolism
Collapse
Affiliation(s)
- Masanori Tamaki
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Aika Hagiwara
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Kazutoshi Miyashita
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Shu Wakino
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Hiroyuki Inoue
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Kentaro Fujii
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Chikako Fujii
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Masaaki Sato
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Masanori Mitsuishi
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Ayako Muraki
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Koichi Hayashi
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Toshio Doi
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| | - Hiroshi Itoh
- Department of Internal Medicine (M.T., A.H., K.M., S.W., H.In., K.F., C.F., M.S., M.M., A.M., K.H., H.It.), School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160-8582, Japan; and Department of Nephrology (M.T., T.D.), Tokushima University Hospital, Kuramoto-cho, Tokushima, 770-8503, Japan
| |
Collapse
|
16
|
Chen JA, Splenser A, Guillory B, Luo J, Mendiratta M, Belinova B, Halder T, Zhang G, Li YP, Garcia JM. Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved. J Cachexia Sarcopenia Muscle 2015; 6:132-43. [PMID: 26136189 PMCID: PMC4458079 DOI: 10.1002/jcsm.12023] [Citation(s) in RCA: 143] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Revised: 11/11/2014] [Accepted: 02/13/2015] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Cachexia and muscle atrophy are common consequences of cancer and chemotherapy administration. The novel hormone ghrelin has been proposed as a treatment for this condition. Increases in food intake and direct effects on muscle proteolysis and protein synthesis are likely to mediate these effects, but the pathways leading to these events are not well understood. METHODS We characterized molecular pathways involved in muscle atrophy induced by Lewis lung carcinoma (LLC) tumour implantation in c57/bl6 adult male mice and by administration of the chemotherapeutic agent cisplatin in mice and in C2C12 myotubes. The effects of exogenous ghrelin administration and its mechanisms of action were examined in these settings. RESULTS Tumour implantation and cisplatin induced muscle atrophy by activating pro-inflammatory cytokines, p38-C/EBP-β, and myostatin, and by down-regulating Akt, myoD, and myogenin, leading to activation of ubiquitin-proteasome-mediated proteolysis and muscle weakness. Tumour implantation also increased mortality. In vitro, cisplatin up-regulated myostatin and atrogin-1 by activating C/EBP-β and FoxO1/3. Ghrelin prevented these changes in vivo and in vitro, significantly increasing muscle mass (P < 0.05 for LLC and P < 0.01 for cisplatin models) and grip strength (P = 0.038 for LLC and P = 0.001 for cisplatin models) and improving survival (P = 0.021 for LLC model). CONCLUSION Ghrelin prevents muscle atrophy by down-regulating inflammation, p38/C/EBP-β/myostatin, and activating Akt, myogenin, and myoD. These changes appear, at least in part, to target muscle cells directly. Ghrelin administration in this setting is associated with improved muscle strength and survival.
Collapse
Affiliation(s)
- Ji-An Chen
- Department of Health Education, College of Preventive Medicine, Third Military Medical University, Chongqing, China.,Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Andres Splenser
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Bobby Guillory
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Jiaohua Luo
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.,Department of Environmental Hygiene, College of Preventive Medicine, Third Military Medical University, Chongqing, China
| | - Meenal Mendiratta
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Blaga Belinova
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Tripti Halder
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Guohua Zhang
- Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX, USA
| | - Yi-Ping Li
- Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX, USA
| | - Jose M Garcia
- Division of Endocrinology, Diabetes and Metabolism, MCL, Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.,Huffington Center on Aging and Dept. of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|
17
|
Callaghan B, Furness JB. Novel and Conventional Receptors for Ghrelin, Desacyl-Ghrelin, and Pharmacologically Related Compounds. Pharmacol Rev 2014; 66:984-1001. [DOI: 10.1124/pr.113.008433] [Citation(s) in RCA: 81] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
|
18
|
Schellekens H, Dinan TG, Cryan JF. Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward. Front Neurosci 2013; 7:148. [PMID: 24009547 PMCID: PMC3757321 DOI: 10.3389/fnins.2013.00148] [Citation(s) in RCA: 63] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2013] [Accepted: 08/01/2013] [Indexed: 12/25/2022] Open
Abstract
The gut hormone, ghrelin, is the only known peripherally derived orexigenic signal. It activates its centrally expressed receptor, the growth hormone secretagogue receptor (GHS-R1a), to stimulate food intake. The ghrelin signaling system has recently been suggested to play a key role at the interface of homeostatic control of appetite and the hedonic aspects of food intake, as a critical role for ghrelin in dopaminergic mesolimbic circuits involved in reward signaling has emerged. Moreover, enhanced plasma ghrelin levels are associated with conditions of physiological stress, which may underline the drive to eat calorie-dense "comfort-foods" and signifies a role for ghrelin in stress-induced food reward behaviors. These complex and diverse functionalities of the ghrelinergic system are not yet fully elucidated and likely involve crosstalk with additional signaling systems. Interestingly, accumulating data over the last few years has shown the GHS-R1a receptor to dimerize with several additional G-protein coupled receptors (GPCRs) involved in appetite signaling and reward, including the GHS-R1b receptor, the melanocortin 3 receptor (MC3), dopamine receptors (D1 and D2), and more recently, the serotonin 2C receptor (5-HT2C). GHS-R1a dimerization was shown to affect downstream signaling and receptor trafficking suggesting a potential novel mechanism for fine-tuning GHS-R1a receptor mediated activity. This review summarizes ghrelin's role in food reward and stress and outlines the GHS-R1a dimer pairs identified to date. In addition, the downstream signaling and potential functional consequences of dimerization of the GHS-R1a receptor in appetite and stress-induced food reward behavior are discussed. The existence of multiple GHS-R1a heterodimers has important consequences for future pharmacotherapies as it significantly increases the pharmacological diversity of the GHS-R1a receptor and has the potential to enhance specificity of novel ghrelin-targeted drugs.
Collapse
|